Prostate Intelligence™
Lucida Medical
| Product specifications |
Information source:
Vendor
Last updated: Oct. 26, 2023 |
| General | |
|---|---|
| Product name | Prostate Intelligence™ |
| Company | Lucida Medical |
| Subspeciality | Abdomen |
| Modality | MR |
| Disease targeted | Prostate cancer |
| Key-features | AI- supported prostate segmentation and volume, lesion segmentation, volumes and risk scores, PI-RADS v2.1 scoring support, structured report |
| Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion, |
| Data characteristics | |
| Population | Prostate MRI scans with suspicion of prostate cancer, males >21 years |
| Input | MRI, T2, DWI, DCE (optional) |
| Input format | DICOM |
| Output | Segmentation overlay, RTSTRUCT export for biopsy and 3D vizualization, structured report with key images, volumes and risk score |
| Output format | DICOM |
| Technology | |
| Integration | Integration in standard reading environment (PACS) |
| Deployment | Locally on dedicated hardware, Cloud-based |
| Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
| Processing time | 1 - 10 minutes |
| Certification | |
|
CE
|
Certified,
Class IIb
, MDR
|
|
FDA
|
No or not yet |
| Market presence | |
| On market since | 05-2021 |
| Distribution channels | Eureka Clinical AI |
| Countries present (clinical, non-research use) | |
| Paying clinical customers (institutes) | |
| Research/test users (institutes) | |
| Pricing | |
| Pricing model | Pay-per-use, Subscription |
| Based on | Number of analyses, Number of installations |
| Evidence | |
| Peer reviewed papers on performance | |
| Non-peer reviewed papers on performance | |
| Other relevant papers |
|